Call Us 072253000
Dr Rachel Joshua Thundyil
Specialty: General Medicine , Rheumatology

Languages: Malay, English

Phone:
07-2253075 Ext: 775
07-2253000



Address:
Sessional Clinic , Clinic 2,
Level 2, Annexe Block,
KPJ Johor Specialist Hospital,
39-B, Jln Abdul Samad,
80100 Johor Bahru, Johor

Clinic open every Thursday

Staff Attached:

Name : Siti Norfadzilah Abd Rashid


About Dr Rachel Joshua Thundyil

Biographical Sketch:


Dr Rachel Joshua Thundyil obtained her MBBS degree from the University of Kerala, South India. She subsequently started her medical career in Queen Elizabeth Hospital, Kota Kinabalu, Sabah. She worked as a medical officer in the Department of General Medicine till December 2004.

In September,2005 she obtained the MRCP degree from the Royal College of Physicians of Ireland.
She did her subspecialty training in Tan Tock Seng Hospital Singapore where she worked as a Registrar in the Department of Rheumatology Allergy and Immunology for a year in 2008 and subsequently at the Rheumatology Unit, Hospital Queen Elizabeth, Kota Kinabalu, Sabah.
She was the acting Head of the Rheumatolgy Unit at Queen Elizabeth Hospital, Kota Kinabalu from January 2014 to Septemeber 2015.

She joined the University Malaysia Sabah as an Associate Professor from September 2015 to September 2016.



Education and Fellowship:

MBBS(INDIA), MRCP (Ireland)



Specialty Interests:

Lupus
Rheumatoid arthritis
Osteoarthritis
Psoriatic arthritis
Ankylosing Spondylitis



Research and Publications:

RESEARCH

1. A multicenter, randomized, double-blind, placebo-controlled trial of golimumab, an anti-TNF monoclonal antibody, administered intravenously, in subjects with active rheumatoid arthritis despite methotrexate therapy.

2. Phase 3, randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of CP-690,550 monotherapy in patients with active rheumatoid arthritis.

3. A long-term, open-label follow-up study of tofacitinib (CP-690,550) for treatment of rheumatoid arthritis (A3921024).

4. A phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of subcutaneous LY2127399 in patients with systemic lupus erythematosus (SLE) (ILLUMINATE-2).

5. A randomized, double-blind, parallel-group study of safety and the effect on clinical outcome of tocilizumab SC versus placebo SC in combination with traditional DMARDS in patients with moderate to severe active rheumatoid arthritis.

6. An observational study of Rheumatoid arthritis patients on adalimumab to Evaluate quality of Life Variables, Effects on work productivity and functional outcomes in Malaysia (RELIVE) Study.

7. A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab(BASE).

8. A randomized, double-blind placebo-controlled study of the maintenance of efficacy of etanercept plus DMARDS(S) compared with DMARDS(S) alone in subjects with rheumatoid arthritis after achieving an adequate response with etanercept plus DMARDS(S).

PUBLICATIONS AND POSTERS

• PREGNANCY OUTCOMES COMPARED IN WOMEN WITH MECHANICAL HEART VALVE REPLACEMENTS ANTICOAGULATED WITH WARFARIN AND ENOXAPARIN IN PREGNANCY.
- Vijayan Valayatham, Rachel Thundyil
- MED J MALAYSIA VOL 67 NO 6 DEC 2012

• THE SPECTRUM OF RHEUMATOID ARTHRITIS POPULATION IN QUEEN ELIZABETH HOSPITAL, SABAH, MALAYSIA.
- RJ Thundyil, T Keowmani, PP Lai, YY Chong
- SSR/MSR 2015 POSTER PRESENTATION, SINGAPORE

• CLINICAL MANIFESTATION AND IMMUNOLOGICAL EXPRESSION OF SLE IN A MULTIETHNIC POPULATION IN SABAH, MALAYSIA.
- Rachel J Thundyil, WK Wong, Thamron Keowmani, Malehah MN, YY Chong
- SECOND PRICE AT THE SABAH MEDICAL RESEARCH AND SCIENTIFIC CONFERENCE 2013

• CLINICAL MANIFESTATIONS AND IMMUNOLOGICAL EXPRESSION OF SLE IN A MULTIETHNIC POPULATION IN SABAH, MALAYSIA
- Rachel J Thundyil, WK Wong, Thamron Keowmani, Malehah MN, YY Chong
- APLAR CHENNAI,2015 POSTER PRESENTATION

• CASE REPORT: INTESTINAL PSEUDO-OBSTRUCTION (IPO) IN SLE
- S Lee, R Thundyil
- FIRST PRICE IN SABAH MEDICAL RESEARCH AND SCIENTIFIC CONFERENCE 2015

• INTESTINAL PSEUDO-OBSTRUCTION (IPO) IN SLE
- S Lee, R Thundyil
- POSTER PRESENTATION AT APLAR, SHANGHAI 2016



Professional Memberships:

Malaysian Rheumatolgy Society (Life Member)
Persatuan SLE Malaysia (Life Member and Medical Advisor)